Show simple item record

dc.contributor.authorKos, F. Tugba
dc.contributor.authorCivelek, Burak
dc.contributor.authorSeker, M. Metin
dc.contributor.authorArik, Zafer
dc.contributor.authorAksoy, Sercan
dc.contributor.authorUncu, Dogan
dc.contributor.authorOzdemir, Nuriye
dc.contributor.authorZengin, Nurullah
dc.date.accessioned2019-07-27T12:10:23Z
dc.date.accessioned2019-07-28T10:04:12Z
dc.date.available2019-07-27T12:10:23Z
dc.date.available2019-07-28T10:04:12Z
dc.date.issued2012
dc.identifier.issn1513-7368
dc.identifier.urihttps://dx.doi.org/10.7314/APJCP.2012.13.12.6151
dc.identifier.urihttps://hdl.handle.net/20.500.12418/9262
dc.descriptionWOS: 000326406300041en_US
dc.descriptionPubMed ID: 23464421en_US
dc.description.abstractBackground: An association between the ABO groups and pancreatic cancer has been shown previously, group A being significantly commoner in affected patients. We conducted the present study to investigate the prognostic effect of ABO blood group on overall survival of pancreas cancer patients. Methods: Patients who were diagnosed between 2005 and 2010 with pancreas cancer at Ankara Numune Education and Research Hospital were analyzed retrospectively. Patient demographics and ABO blood groups were obtained from medical charts. Results: Fifty pancreas cancer patients with known ABO blood group were included, 26 (52%) group A, 12 patients (24%) group 0, 9 (18%) group B, and 3 (6%) group AB. Blood group A pancreas cancer patient median age was 61.5 (39-80) years, with the median age of the other blood groups (B,AB,O) being 55.5 (32-74) years (p=0.14). 18% of patients with blood group A and11% of the other blood group patients had metastasis (p=0.17) at the time of diagnosis. The median overall survival of blood group A pancreas patients was significantly lower than the other blood group patients, 7.6 (95% CI: 5.0-10.2) months versus 29.0 (95% CI: 0.0-68.8) months (p=0.05). Conclusions: Acccording to previously published cohort studies a relation may exist between ABO blood groups and cancer of pancreas. In this study we observed that pancreas cancer patients with blood group A have significantly worse overall survival than other blood groups.en_US
dc.language.isoengen_US
dc.publisherASIAN PACIFIC ORGANIZATION CANCER PREVENTIONen_US
dc.relation.isversionof10.7314/APJCP.2012.13.12.6151en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectBlood groupsen_US
dc.subjectpancreas canceren_US
dc.subjectsurvivalen_US
dc.subjectTurkeyen_US
dc.titleIs There an Association between Blood Group and Survival in Pancreatic Cancer?en_US
dc.typearticleen_US
dc.relation.journalASIAN PACIFIC JOURNAL OF CANCER PREVENTIONen_US
dc.contributor.department[Kos, F. Tugba] Kahramanmaras Sutcu Imam Univ, Dept Med Oncol, Fac Med, TR-46050 Kahramanmaras, Turkey -- [Arik, Zafer -- Aksoy, Sercan] Hacettepe Univ, Inst Oncol, Dept Med Oncol, Ankara, Turkey -- [Seker, M. Metin] Cumhuriyet Univ, Fac Med, Dept Med Oncol, Sivas, Turkeyen_US
dc.contributor.authorIDAksoy, Sercan -- 0000-0003-4984-1049en_US
dc.identifier.volume13en_US
dc.identifier.issue12en_US
dc.identifier.endpage6153en_US
dc.identifier.startpage6151en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record